QUOD biobank materials and data were used by research groups in studies that generated the following publications and presentations.
Did we miss one? Please let us know by emailing quod-research@nds.ox.ac.uk.
Publications
- Neri F, Lo Faro ML, Kaisar M, Tam KH, Borak M, Lindeman J, Angelini A, Fedrigo M, Kers J, Hunter J, Ploeg R
Renal biopsies from donors with acute kidney injury show different molecular patterns according to the post-transplant function
Sci Rep. 2024;14(1):6643. doi:10.1038/s41598-024-56277-x - Lo Faro ML, Rozenberg K, Huang H, Maslau S, Bonham S, Fischer R, Kessler B, Leuvenink H, Sharples E, Lindeman JH, Ploeg R.
Kidney tissue proteome profiles in short versus long duration of delayed graft function – a pilot study in donation after circulatory death donors
Kidney Int Rep. 2024;9(5):1473–1483. doi:10.1016/j.ekir.2024.02.012 - Shapey IM, Summers A, O’Sullivan J, Fullwood C, Hanley NA, Casey J, Forbes S, Rosenthal M, Johnson PRV, Choudhary P, Bushnell J, Shaw JAM, Neiman D, Shemer R, Glaser B, Dor Y, Augustine T, Rutter MK, van Dellen D.
Beta-cell death and dysfunction drives hyperglycaemia in organ donors
Diabetes Obes Metab. 2023;25(12):3529–3537. doi: 10.1111/dom.15248 - Vaughan RH, Kresse JC, Farmer LK, Thézénas ML, Kessler BM, Lindeman JHN, Sharples EJ, Welsh GI, Nørregaard R, Ploeg RJ, Kaisar M.
Cytoskeletal protein degradation in brain death donor kidneys associates with adverse posttransplant outcomes
Am J Transplant. 2022 Apr;22(4):1073-1087. doi: 10.1111/ajt.16912 - Russell CD, Valanciute A, Gachanja NN, Stephen J, Penrice-Randal R, Armstrong SD, Clohisey S, Wang B, Al Qsous W, Wallace WA, Oniscu GC, Stevens J, Harrison DJ, Dhaliwal K, Hiscox JA, Baillie JK, Akram AR, Dorward DA, Lucas CD.
Tissue proteomic analysis identifies mechanisms and stages of immunopathology in fatal COVID-19
Am J Respir Cell Mol Biol. 2022;66(2):196–205. doi:10.1165/rcmb.2021-0358OC - White M, Maheshwari R, Anderson S, Berlinguer-Palmini R, Jones C, Richardson S, Rotti P, Armour S, Ding Y, Krasnogor N, Engelhardt J, Gray M, Morgan N, Shaw J.
In situ analysis reveals that CFTR is expressed in only a small minority of β-cells in normal adult human pancreas
J Clin Endocrinol Metab. 2020 May 1;105(5):1366–1374. doi: 10.1210/clinem/dgz209 - Jassem W, Xystrakis E, Ghnewa Y, Yuksel M, Pop O, Martinez-Llordella M, Jabri Y, Huang X, Lozano J, Quaglia A, Sanchez-Fueyo A, Coussios C, Rela M, Friend P, Heaton N, Ma Y
Normothermic machine perfusion (NMP) inhibits proinflammatory responses in the liver and promotes regeneration
Hepatology. 2019 Aug;70(2):682–695. doi: 10.1002/hep.30475 - Kaisar M, van Dullemen L, Charles P, Akhtar ZM, Thézénas ML, Huang H, Klooster A, Watkins NA, Kessler B, Ploeg RJ.
Subclinical changes in deceased donor kidney proteomes are associated with 12-month allograft function post transplantation–a preliminary study
Transplantation. 2019 Feb;103(2):323–328. doi: 10.1097/TP.0000000000002358 - Chong S, Atkinson C, Banga N, Harber M, Reeves M, Magee, C
Association between donor/recipient BK viral serostatus and risk of BK viraemia post-transplantation
Transplantation. 2018;102:S567. doi:10.1097/01.tp.0000543438.89653.23 - Khorsandi SE, Salehi S, Cortes M, Vilca-Melendez H, Menon K, Srinivasan P, Prachalias A, Jassem W, Heaton N.
An in silico argument for mitochondrial microRNA as a determinant of primary non function in liver transplantation
Sci Rep. 2018 Feb 15;8(1):3105. doi: 10.1038/s41598-018-21091-9 - Kaisar M, van Dullemen L, Thézénas ML, Akhtar Z, Huang H, Rendel S, Charles P, Fischer R, Ploeg R, Kessler B
Plasma degradome affected by variable storage of human blood
Clin Proteomics. 2016;13:26. doi:10.1186/s12014-016-9126-9
Presentations
- Shaheed S. ‘Multi-omics approach to identify the molecular signature of primary non-function prior to transplantation in deceased donor kidneys’
Poster presentation at the ASMS Conference on Mass Spectrometry and Allied Topics | Anaheim, California, USA | June 2024 - Michelakis I. ‘The role of donor cystatin-C in posttransplant outcomes in kidney transplantation’
Oral presentation at ERA2024 | Stockholm, Sweden | May 2024 (Abstract) - Lucas C. ‘SARS-CoV-2 pathology in humans’
UK International Coronavirus Network meeting | Nicosia, Cyprus | 2024 - Russell C. ‘Treatable traits in Covid-19 immunopathology’
Invited online talk at Hull Academic Infectious Diseases/Microbiology seminar | Hull, UK | October 2022 - Dorward D. ‘COVID-19 lung pathology – IHC studies and the UK experience’
Pulmonary Pathology Society | Cork, Ireland | June 2022 - Russell CD. ‘Treatable traits in Covid-19 immunopathology’
Oral presentation at Infectious Diseases Unit seminar | Edinburgh, UK | May 2022 - Russell C, Dorward D. ‘Tissue proteomic analysis identifies mechanisms and stages of immunopathology in fatal COVID-19’
Poster presentation at Scottish Immunology Groups Network | Perth, UK | March 2022 - Russell C. ‘Treatable traits in Covid-19’
Invited talk presented at 8th Pharmacogenetics and Stratified Medicine Network | London, UK | October 2021 - Dorward D, Russell CD. ‘Lessons from ICECAP COVID-19 post-mortem study’
NHS Lothian Grand Round | Edinburgh, UK | September 2021 - Kaisar M, et al. ‘Activated cytoprotective mechanisms in DBD kidneys correlate with kidney function in transplant recipients: a study using clinical samples from the UK QUOD biobank’
Oral presentation at the 2016 American Transplant Congress | Boston, Massachusetts, USA | June 2016 (Abstract)